The modulation of the autophagy pathway by miR-223 with the involvement of FOXO3a intermediates re-sensitized drug-resistant cells of hepatocellular carcinoma and improved the therapeutic resistance and prognosis of hepatocellular carcinoma cells. This evidence concerns the gene FOXO3 and hepatocellular carcinoma.